Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R W Pitt

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Non-peptide oxytocin agonistsGary R W Pitt, Andrzej R Batt, Robert M Haigh, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2013
Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZNeil R Stokes, Nicola Baker, James M Bennett, et al.
Journal of Medicinal Chemistry|December 5, 2008
New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonistsChristopher M Yea, Christine E Allan, Doreen M Ashworth, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2014
Discovery and in vivo evaluation of alcohol-containing benzothiazoles as potent dual-targeting bacterial DNA supercoiling inhibitorsJames T Palmer, Lorraine C Axford, Stephanie Barker, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2013
Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitorsLorraine C Axford, Piyush K Agarwal, Kelly H Anderson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Non-peptide oxytocin agonistsGary R W Pitt, Andrzej R Batt, Robert M Haigh, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2013
Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZNeil R Stokes, Nicola Baker, James M Bennett, et al.
Journal of Medicinal Chemistry|December 5, 2008
New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonistsChristopher M Yea, Christine E Allan, Doreen M Ashworth, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2014
Discovery and in vivo evaluation of alcohol-containing benzothiazoles as potent dual-targeting bacterial DNA supercoiling inhibitorsJames T Palmer, Lorraine C Axford, Stephanie Barker, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2013
Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitorsLorraine C Axford, Piyush K Agarwal, Kelly H Anderson, et al.
Pageof 1